Literature DB >> 27071757

Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.

Tiziana Cavalli1, Francesco Giudici2, Raffaella Santi2, Gabriella Nesi2, Maria Luisa Brandi2, Francesco Tonelli2.   

Abstract

Sporadic VIPoma is an exceedingly rare tumor with an annual incidence of 1:10 million people worldwide, yet it is described in approximately 5 % of MEN1 patients. The majority of VIPomas are malignant and radical surgery is the best therapeutic option. A 58-year-old man presented with cardiocirculatory arrest due to ventricular fibrillation. The patient had a 3-month history of epigastric pain with diarrhea. After reanimation, laboratory data revealed severe hypokalemia and hypercalcemia. Further investigations showed hyperparathyroidism, left adrenal adenoma and pituitary microprolactinoma and genetic diagnosis of MEN1 syndrome was made. Abdominal computed tomography revealed a 45 × 30 mm mass of the pancreatic head and two hepatic lesions, which proved to be neuroendocrine after 68 Ga PET and needle biopsy. Vasoactive intestinal peptide (VIP) serum level had increased. Subsequently the patient underwent pylorus-preserving pancreaticoduodenectomy and hepatic resection. Intraoperative VIP returned to normal values. Histopathology confirmed a pancreatic VIPoma metastatic to the liver. The postoperative course was unremarkable and the patient is well with no evidence of disease at a 48 months follow-up. Even in case of anusual presentation, when two or more main clinical findings of MEN1 related tumors are present, unrespectively to the presence of MEN1 mutation, MEN1 syndrome should be suspected. Surgery in MEN1 pancreatic neuroendocrine tumors is indicated both to treat symptoms and to avoid oncological progression even in advanced cases.

Entities:  

Keywords:  MEN1; PNET; Surgery; VIPoma; Ventricular fibrillation

Mesh:

Year:  2016        PMID: 27071757     DOI: 10.1007/s10689-016-9906-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

Review 1.  Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma.

Authors:  Shu You Peng; Jiang Tao Li; Ying Bin Liu; He Qing Fang; Yu Lian Wu; Chen Hong Peng; Xin Bao Wang; Hao Ran Qian
Journal:  Pancreas       Date:  2004-01       Impact factor: 3.327

2.  Prevention of hypoglycemic attacks by propranolol in a patient suffering from insulinoma.

Authors:  I Blum; M Doron; Z Laron; A Atsmon; P Tiqva
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

3.  Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.

Authors:  Toshiyuki Hasegawa; Kenji Yamao; Susumu Hijioka; Vikram Bhatia; Nobumasa Mizuno; Kazuo Hara; Hiroshi Imaoka; Yasumasa Niwa; Masahiro Tajika; Shinya Kondo; Tutomu Tanaka; Yasuhiro Shimizu; Taira Kinoshita; Takuhiro Kohsaki; Isao Nishimori; Shinji Iwasaki; Toshiji Saibara; Waki Hosoda; Yasushi Yatabe
Journal:  Endoscopy       Date:  2013-11-11       Impact factor: 10.093

4.  Consensus guidelines for the management and treatment of neuroendocrine tumors.

Authors:  Pamela L Kunz; Diane Reidy-Lagunes; Lowell B Anthony; Erin M Bertino; Kari Brendtro; Jennifer A Chan; Herbert Chen; Robert T Jensen; Michelle Kang Kim; David S Klimstra; Matthew H Kulke; Eric H Liu; David C Metz; Alexandria T Phan; Rebecca S Sippel; Jonathan R Strosberg; James C Yao
Journal:  Pancreas       Date:  2013-05       Impact factor: 3.327

Review 5.  Multi-detector row CT of pancreatic islet cell tumors.

Authors:  Karen M Horton; Ralph H Hruban; Charles Yeo; Elliot K Fishman
Journal:  Radiographics       Date:  2006 Mar-Apr       Impact factor: 5.333

6.  Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine.

Authors:  C A Sninsky; M M Wolfe; J L Martin; B A Howe; T M O'Dorisio; J E McGuigan; J R Mathias
Journal:  Am J Physiol       Date:  1983-01

Review 7.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

8.  Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.

Authors:  M G Kane; T M O'Dorisio; G J Krejs
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

9.  [Acute renal failure caused by VIP-secreting tumor].

Authors:  D Lambertini; E Bottini; E Talassi; R Tarchini; L Gaetti; A Bellomi
Journal:  G Ital Nefrol       Date:  2003 Jul-Aug

10.  Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome.

Authors:  Rushikesh Raviraj Maheshwari; Madhav Desai; Vara Prasada G Rao; Radha Rani Palanki; Rajendra Prasad Namburi; Karthik T S Reddy; Amaresh P Reddy
Journal:  Indian J Endocrinol Metab       Date:  2013-10
View more
  3 in total

Review 1.  Treatment options of metastatic and nonmetastatic VIPoma: a review.

Authors:  Azadeh Azizian; Alexander König; Michael Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2022-08-05       Impact factor: 2.895

2.  Paediatric VIPoma: A Jamboree of Electrolytes.

Authors:  Amit Rastogi; Vansh Priya; Rudrashish Haldar; Rameez Riaz
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-11-29

3.  Prevalence of Diagnostic Methods and Treatment Modalities in Vipoma Patients: A Rare Cause of Hormone-Mediated Diarrhea.

Authors:  Fateme Shamekhi Amiri
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.